
Rewiring the Brain for Tomorrow
NeuroVista Labs
Advancing Therapies to Unlock Neuroplasticity Potential
Innovative Biotech for CNS Disorders
NeuroVista Labs is pioneering small-molecule TrkB agonists, focused on enhancing neuroplasticity to address unmet needs in central nervous system disorders and improve patient outcomes, with a focus on Alzheimer's disease.
150+
2+
Primary leads
Analogs tested
Innovative CNS Solutions
Developing small-molecule therapies to enhance neuroplasticity and treat CNS disorders effectively.
Targeted Small Molecules
Unlocking potential for neuroplasticity in CNS diseases through innovative drug development.
Research and Development
Pioneering advancements in CNS therapies with a focus on TrkB agonists.
Partnership Opportunities
Collaborate with us to drive innovation in neurotherapeutics and expand treatment options.
Our company
Innovative small-molecule therapies for CNS disorders and neuroplasticity.


Lead Programs
Focused on NVL-19 and NVL-20 development and research.


Our team and collaborators
Partnering with experts to advance our scientific discoveries.
Get in Touch
We welcome your inquiries and partnerships. Contact us to learn more about our innovative research and development in CNS disorders.
Contact
Get in touch for partnership and inquiries.
info@neurovistalabs.com.br
+1 (786) 979-7926
© 2025. All rights reserved.
